BioSpace is proud to present its NextGen Bio “Class of 2023,” a list of the hottest recently launched life sciences companies in North America.
To come up with this list, BioSpace evaluated companies that launched between September 2021 and September 2022 with Series A funding. They were then assessed using several different criteria and ranked in a cumulative fashion, based on the points awarded for each category. These categories were: finance, partnerships, pipeline, growth potential and innovation.
The NextGen Bio Class of 2023 is an impressive group of startups that are already making a significant impact on the industry now and will continue to do so into the future. Congratulations to this group of winners!